Abstract
Papillary carcinoma of the thyroid is a common malignancy originating from the endocrine organs. The recent prevalence of ultrasonography (US) and US-guided fine needle aspiration biopsy (FNAB) can make us easily diagnose papillary carcinoma of 1.0 cm or less in maximal diameter, which is called papillary microcarcinoma. How to treat papillary microcarcinoma has been controversial. In autopsy studies, papillary carcinoma of 3-9.9 mm is frequently found as an occult carcinoma. Furthermore, papillary carcinoma of more than 3 mm was detected in 3.5% of otherwise healthy women aged 30 years or older by mass screening using US and FNAB, and 84% of them were less than 1.5 cm in diameter. These findings indicate that papillary microcarcinoma frequently remains occult. Thus, recently, a trial of observation without surgical treatment has been performed, which demonstrates that most papillary microcarcinoma do not grow or only slowly grow and observation can be a therapeutic strategy. On the other hand, previous reports demonstrated that papillary microcarcinoma frequently metastasizes to cervical lymph nodes and shows multiple tumor formation in the thyroid. Furthermore, cases with palpable nodal metastasis often show rapid progression and dire prognosis. In this review, we discuss the appropriate application of observation and surgical treatment of papillary microcarcinoma.
Keywords: thyroid cancer, microcarcinoma, surgery, observation
Current Cancer Therapy Reviews
Title: Therapeutic Strategies for Papillary Microcarcinoma of the Thyroid
Volume: 1 Issue: 1
Author(s): Yasuhiro Ito and Akira Miyauchi
Affiliation:
Keywords: thyroid cancer, microcarcinoma, surgery, observation
Abstract: Papillary carcinoma of the thyroid is a common malignancy originating from the endocrine organs. The recent prevalence of ultrasonography (US) and US-guided fine needle aspiration biopsy (FNAB) can make us easily diagnose papillary carcinoma of 1.0 cm or less in maximal diameter, which is called papillary microcarcinoma. How to treat papillary microcarcinoma has been controversial. In autopsy studies, papillary carcinoma of 3-9.9 mm is frequently found as an occult carcinoma. Furthermore, papillary carcinoma of more than 3 mm was detected in 3.5% of otherwise healthy women aged 30 years or older by mass screening using US and FNAB, and 84% of them were less than 1.5 cm in diameter. These findings indicate that papillary microcarcinoma frequently remains occult. Thus, recently, a trial of observation without surgical treatment has been performed, which demonstrates that most papillary microcarcinoma do not grow or only slowly grow and observation can be a therapeutic strategy. On the other hand, previous reports demonstrated that papillary microcarcinoma frequently metastasizes to cervical lymph nodes and shows multiple tumor formation in the thyroid. Furthermore, cases with palpable nodal metastasis often show rapid progression and dire prognosis. In this review, we discuss the appropriate application of observation and surgical treatment of papillary microcarcinoma.
Export Options
About this article
Cite this article as:
Ito Yasuhiro and Miyauchi Akira, Therapeutic Strategies for Papillary Microcarcinoma of the Thyroid, Current Cancer Therapy Reviews 2005; 1 (1) . https://dx.doi.org/10.2174/1573394052952546
DOI https://dx.doi.org/10.2174/1573394052952546 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In Vivo Tumor Secretion Probing Via Ultrafiltration and Tissue Chamber:Implication for Anti-Cancer Drugs Targeting Secretome
Recent Patents on Anti-Cancer Drug Discovery Targeting the Tumor Stroma in Cancer Therapy
Current Pharmaceutical Biotechnology Cutaneous Melanoma: A Test Field for Immunotherapy and a Medical Challenge
Current Cancer Therapy Reviews CircRNAs and Axes Involved in Thyroid Cancer based on PTC: A Biomarker for Prognosis, Diagnosis and Treatment
Current Signal Transduction Therapy Blockade of Insulin-Like Growth Factor Type-1 Receptor with Cixutumumab (IMC-A12): A Novel Approach to Treatment for Multiple Cancers
Current Drug Targets Therapeutics Based on microRNA: A New Approach for Liver Cancer
Current Genomics Novel and Emerging Targeted Therapies of Colorectal Cancer
Current Clinical Pharmacology Dipeptidyl Peptidase-4 Inhibition: Linking Chemical Properties to Clinical Safety
Current Medicinal Chemistry Subject Index to Volume 3
Current Medicinal Chemistry - Anti-Cancer Agents Thyroid Hormones and Cardiovascular System: From Bench to Bedside
Current Drug Therapy Antioxidants as a Potential Preventive and Therapeutic Strategy for Cadmium
Current Drug Targets Clinical Applications of Non-Antimicrobial Actions of Tetracyclines in Inflammatory Diseases
Current Drug Therapy Nuclear Receptors: Overview and Classification
Current Drug Targets - Inflammation & Allergy Focus on the Role of Glutamate in the Pathology of the Peripheral Nervous System
CNS & Neurological Disorders - Drug Targets Restless Legs Syndrome/Willis-Ekbom Disease and Periodic Limb Movements: A Comprehensive Review of Epidemiology, Pathophysiology, Diagnosis and Treatment Considerations
Current Rheumatology Reviews Clinical Impact of the Detection of BRAF Mutations in Thyroid Pathology: Potential Usefulness as Diagnostic, Prognostic and Theragnostic Applications
Current Medicinal Chemistry Developments of Combretastatin A-4 Derivatives as Anticancer Agents
Current Medicinal Chemistry Extranuclear Localization of SIRT1 and PGC-1α: An Insight into Possible Roles in Diseases Associated with Mitochondrial Dysfunction
Current Molecular Medicine Are Selenoproteins Important for the Cancer Protective Effects of Selenium?
Current Nutrition & Food Science Metabolic Control of Type 2 Diabetes by Targeting the GLUT4 Glucose Transporter: Intervention Approaches
Current Pharmaceutical Design